NasdaqGS - Nasdaq Real Time Price USD
Vaxcyte, Inc. (PCVX)
29.00
-0.24
(-0.82%)
At close: May 7 at 4:00:01 PM EDT
29.10
+0.10
+(0.34%)
Pre-Market: 5:00:38 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
569,546
569,546
393,041
209,261
102,085
Operating Income
-569,546
-569,546
-393,041
-209,261
-102,085
Net Non Operating Interest Income Expense
109,994
109,994
62,907
8,354
337
Other Income Expense
-4,375
-4,375
-72,132
-22,578
1,671
Pretax Income
-463,927
-463,927
-402,266
-223,485
-100,077
Net Income Common Stockholders
-463,927
-463,927
-402,266
-223,485
-100,077
Diluted NI Available to Com Stockholders
-463,927
-463,927
-402,266
-223,485
-100,077
Basic EPS
-3.80
--
-4.14
-3.44
-1.93
Diluted EPS
-3.80
--
-4.14
-3.44
-1.93
Basic Average Shares
121,997.35
--
97,157.69
64,877.99
51,922.11
Diluted Average Shares
121,997.35
--
97,157.69
64,877.99
51,922.11
Total Operating Income as Reported
-569,546
-569,546
-468,041
-232,256
-103,670
Total Expenses
569,546
569,546
393,041
209,261
102,085
Net Income from Continuing & Discontinued Operation
-463,927
-463,927
-402,266
-223,485
-100,077
Normalized Income
-463,927
-463,927
-327,266
-200,490
-101,748
Interest Income
109,994
109,994
62,907
8,356
344
Interest Expense
0
0
0
2
7
Net Interest Income
109,994
109,994
62,907
8,354
337
EBIT
-463,927
-463,927
-402,266
-223,483
-100,070
EBITDA
-448,082
-448,082
-392,095
-214,030
-96,613
Reconciled Depreciation
15,845
15,845
10,171
9,453
3,457
Net Income from Continuing Operation Net Minority Interest
-463,927
-463,927
-402,266
-223,485
-100,077
Total Unusual Items Excluding Goodwill
0
0
-75,000
-22,995
1,671
Total Unusual Items
0
0
-75,000
-22,995
1,671
Normalized EBITDA
-448,082
-448,082
-317,095
-191,035
-98,284
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/12/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACLX Arcellx, Inc.
52.94
+0.27%
CYTK Cytokinetics, Incorporated
33.04
-2.74%
RNA Avidity Biosciences, Inc.
26.17
-0.34%
NUVL Nuvalent, Inc.
66.72
-2.16%
KRYS Krystal Biotech, Inc.
136.80
-1.91%
PTCT PTC Therapeutics, Inc.
40.76
+12.63%
RVMD Revolution Medicines, Inc.
37.66
+0.59%
LEGN Legend Biotech Corporation
31.47
+0.32%
APLS Apellis Pharmaceuticals, Inc.
17.99
-5.91%
IMVT Immunovant, Inc.
13.88
+0.29%